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resumo 
 
 
O Grafeno é constituído por uma única camada de átomos de carbono, 
estruturada em forma hexagonal com os átomos de carbono ligados por 
hibridação sp2 e, desde o seu isolamento as suas propriedades únicas, tais 
como, grande área superficial, condutividade elétrica e térmica, têm sido 
bastante estudadas. Os nanomateriais de grafeno e os que são à base de 
grafeno são atualmente aplicados em várias áreas, tais como medicina, 
eletrónica, sensores e ambiente. Apesar da ampla aplicação dos 
nanomateriais de grafeno, as informações sobre os riscos para a saúde 
humana e o meio ambiente não são ainda bem conhecidas. 
Consequentemente, é importante investigar e avaliar a potencial toxicidade do 
grafeno. Esta tese revê as aplicações e a toxicidade da Família dos 
Nanomateriais de Grafeno (GFNs) em células humanas. Além disso, os 
ensaios para a avaliação in vitro dos efeitos genotóxicos também foram 
brevemente revistos. A relevância da avaliação dos potenciais efeitos 
genotóxicos das GFNs é destacada nesta tese. 
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abstract Graphene is a purely carbon-based, honeycomb-structured, one-atom thick 
layer of carbon atoms, bonded to another by sp2 hybridization and since its 
isolation, its unique properties such as high surface area, electrical and thermal 
conductivities have been widely studied. Graphene and graphene-based 
nanomaterials are now applied in several fields, as for instance medicine, 
electronics, sensors and environment. Despite the wide application of graphene 
nanomaterials, the information on the risks to human health and the 
environment are not yet well known. Consequently, it is important to investigate 
and evaluate the potential toxicity of graphene. This thesis revises the 
applications and toxicity of Graphene-Family Nanomaterials (GFNs) to human 
cells. Also, the assays for in vitro evaluation of genotoxic effects were also 
shortly revised. The relevance of the evaluation of potential genotoxic effects of 
GFNs is highlighted in this thesis. 
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I. Introduction  
 
 
Nanotechnology 
 
Nanotechnology is the science that studies and develops technology at the 
atomic, molecular and macromolecular scale, leading to the controlled manipulation 
of structures and devices with domain dimensions below 100 nm (McNeil, 2005; 
Nowack & Bucheli, 2007). It exploits chemical, physical, electrical, and mechanical 
properties that emerge when matter is structured at the nanoscale (Buzea et al.,  
2007). Engineered nanoparticles have become an important class of new materials 
with several properties that make them very attractive for commercial development. 
Due to such a small scale of manipulation, the materials produced with the help of 
nanotechnology find their potential applications in many different fields, such as 
electronics, aerospace, computer industry, cosmetics and biomedical research (Fig. 
1) (Medina et al., 2009; Hyuk et al., 2010).  
 
 
 
 
 
 
 
 
 
 
An obvious advantage of nanotechnology is the ability to control the size of 
the resulting particles and devices. Nanoscale devices and components are of the 
same basic size as biological entities. Individual nanoscale particles can also provide 
remarkable analytical sensitivity in a variety of biological assays, in real time and 
without the use of radioisotopes (McNeil, 2005). 
Figure 1. Applications of Nanotechnology. 
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Although nanotechnology is a relatively young field, it is developing rapidly, 
thanks to a strong foundation of material science and engineering. Because of the 
potential of this technology there has been an increase in investment in 
nanotechnology research and development (Guzman et al., 2006). Despite of their 
unique advantages and applications in domestic and industrial sectors, use of 
materials with dimensions in nanometres has raised the issue of safety for workers, 
consumers and the environment (Sajid et al., 2015).  
 
 
Nanomaterials Definition and Classification  
 
In 2011, the European Commission defined a nanomaterial as “a natural, 
incidental or manufactured material containing particles in an unbound state or as 
an aggregate or as an agglomerate and where, for 50% or more of the particles in 
the number size distribution, one or more external dimensions is in the size range 
1 nm - 100 nm” (Fig. 2). Also, the “fullerenes, graphene flakes and single wall 
carbon nanotubes with one or more external dimensions below 1 nm should be 
considered as nanomaterials” (European Commission, 2011).  
 
 
 
 Figure 2. A size comparison of nanoparticle with other larger-sized materials. Adapted from Amin et al. (2014). 
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 Nanoparticles (NPs) have unique physical and chemical properties resulting 
from the high amount of atoms present on the surface, their increased surface area 
to volume ratio and extremely small size (Ghosh & Paria, 2012). NPs are therefore 
considered substances that are less than 100 nm in size in more than one dimension. 
As can be seen in Figure 3, a nanoparticle is 100–10,000 times smaller than the size 
of a mammalian cell.  
 
 
Figure 3. A mammalian cell is thousand times larger in volume and size compared to a 10 nm nanoparticle. 
Adapted from Hyuk et al. (2009). 
 
 
 
 NPs can be spherical, tubular, or irregularly shaped and can exist in fused, 
aggregated or agglomerated forms. They can be classified into natural and 
anthropogenic (engineered) particles (Nowack & Bucheli, 2007). Nanoparticles may 
be composed of minerals, metals or organic compounds and may also be mixtures 
of variable complexity depending on the method used to generate them (Andujar 
et al., 2011).  
The interface between a nanoparticle and biological systems comprises three 
interacting components: the nanoparticle surface, the solid–liquid interface; and the 
solid–liquid interface’s contact zone with biological substrates (Nel et al., 2009) (Fig. 
4). These interactions are shaped by a great number of forces that could determine 
whether the nanoparticle is bioavailable and may participate in biocompatible or bio 
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adverse interactions. Processes as the formation of the protein corona, cellular 
contact, particle wrapping at cell surfaces, endocytosis and intracellular biocatalysis 
are determined by specific interactions (Nel et al., 2009). 
The acquired properties of nanoparticles contribute actively for the 
interaction of nanoparticles with the biological medium. However, forces like long-
range forces, which arises from van der Waals (attractive in nature) and electrostatic 
double layer interactions, and short range forces, which arise from charge, solvent 
interaction, steric hindrance and depletion are found at the nanoparticle media 
interface responsible for interaction with biomolecules (Nel at al., 2009).  
The biophysicochemical inﬂuences on the interface between nanomaterials 
and biological systems are represented in table 1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Representation of the interface between a nanoparticle and a lipid bilayer. Adapted 
from Nel et al. (2009). 
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Table 1. Main biophysicochemical inﬂuences on the interface between nanomaterials and biological 
systems (Nel et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nanoparticle  
Size, shape and surface area 
Surface charge, energy, roughness and porosity 
Valence and conductance states 
Functional groups 
Ligands 
Crystallinity and defects 
Hydrophobicity and hydrophilicity 
Suspending media 
Water molecules 
Acids and bases 
Salts and multivalent ion 
Natural organic matter (proteins, lipids) 
Surfactants 
Polymers 
Polyelectrolytes 
Solid–liquid interface 
Surface hydration and dehydration 
Surface reconstruction and release of free surface energy 
Ion adsorption and charge neutralization 
Electrical double-layer formation, zeta potential, isoelectric point 
Sorption of steric molecules and toxins 
Electrostatic, steric and electrosteric interactions 
Aggregation, dispersion and dissolution 
Hydrophilic and hydrophobic interactions 
Nano–bio interface 
Membrane interactions: specific and nonspecific forces 
Receptor–ligand binding interactions 
Membrane wrapping: resistive and promotive forces 
Biomolecule interactions (lipids, proteins, DNA) leading to structural and 
functional effects 
Free energy transfer to biomolecules 
Conformational change in biomolecules 
Oxidant injury to biomolecules 
Mitochondrial and lysosomal damage, decrease in ATP 
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Nanotoxicology 
 
Nanotoxicology is a branch of toxicology that can be defined as the study of 
the toxicity of nanomaterials. Humans have been exposed to naturally formed 
nanoparticles throughout their evolution; however, this exposure has been 
increased due to arise of engineered manufactured nanomaterials (ENMs) (Medina 
et al., 2009).  
Humans can be exposed to nanoparticles by several exposure routes, such 
as inhalation, ingestion, dermal penetration, injection or implantation for biomedical 
applications (Buzea et al., 2007).  
In a context of work place exposure, inhalation is a major route of exposure 
and this can occur in different stages of the manufacturing cycle such as in the 
production of the nanomaterial or during its incorporation into final products. 
Exposure as a result of product disposal is also possible through the release of 
nanomaterials into watercourses (Maynard, 2012). Nanoparticles can be easily 
deposited in the lungs or on the skin, and have the ability to redistribute from their 
site of deposition. Agglomerates of nanoparticles larger than 100nm in diameter can 
also be inhaled, ingested or deposited on the skin, and may have the potential to 
express toxicity associated with their nanostructure (Oberdörster et al., 2005).   
The routes of exposure to nanoparticles and its effects are illustrated in figure 
5.  Some of the diseases associated with inhaled NPs are asthma, bronchitis, lung 
cancer, and neurodegenerative diseases, such as Parkinson’s disease. Presence of 
NPs in the gastrointestinal tract have been linked to Crohn’s disease and colon 
cancer. Occurrence of arteriosclerosis, blood clots, arrhythmia and heart diseases 
are related to nanoparticles that enter the circulatory system. Autoimmune diseases, 
such as systemic lupus erythematosus and rheumatoid arthritis may occur due to 
exposure to some NPs (Buzea et al., 2007). 
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Features such as NP size, shape, surface properties, composition, solubility, 
aggregation/agglomeration, particle uptake, and the presence of mutagens can 
influence the mechanisms of toxicity (Fig. 6). The smaller particles are, higher is the 
surface area they have per unit mass; and this property makes nanoparticles very 
reactive in the cellular environment. Therefore, any intrinsic toxicity of the particle 
surface will be enhanced (Donaldson et al., 2004). It is important to mention that 
the toxicity of any nanomaterial to an organism depends on the individual’s genetic 
complement, which provides the biochemical tools needed to adapt and fight toxic 
substances (Buzea et al., 2007).  
 
Figure 5. Schematics of human body with pathways of exposure to nanoparticles, affected organs and 
associated diseases. Adapted from Buzea et al. (2007). 
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Figure 6. Physiochemical properties of nanomaterials leading to nanotoxicology. 
 
 
 
Genotoxicity can be generated by direct interaction of nanoparticles with the 
genetic material, by indirect damage from NP-induced ROS, or by toxic ions released 
due to NPs solubilization.  NPs that cross cellular membranes may be able to reach 
the nucleus through diffusion across the nuclear membrane or transportation 
through the nuclear pore complexes, and interact directly with DNA organised in 
chromatin or chromosomes (Magdolenova et al., 2014).  
Some studies describe de ability of NPs to travel via the nasal nerves to the 
brain, as has been described for polio virus, and to gain access to the blood and 
other organs. They may not be detected by the normal phagocytic defences, 
allowing them to gain access to the blood or the nervous system.  NPs can trigger 
ROS production in activated phagocytes (neutrophils, macrophages). 
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Graphene Nanomaterials 
 
Graphene is a purely carbon-based, honeycomb-structured, one-atom thick 
layer of carbon atoms, bonded to another by sp2 hybridization, resulting in a large 
surface area on both sides of the planar axis. Its most frequent form in nature is 
graphite, a mere stack of graphene layers held together by Van der Waals 
interactions (Fig. 7) (Geim and Novoselov, 2007; Novoselov, 2004).  
 
  
 
 
 
 
 
 
 
The theoretical existence of graphene was discussed over 60 years ago by 
Slonczewski and Weiss (1958).  However, in 2004, Geim and Novoselov isolated 
single sheets of graphene by micromechanical cleavage of graphite and 
characterized their quantum electrodynamics (Novoselov et al., 2004).  
Graphene and its derivatives, referred to as graphene family nanomaterials 
(GFNs), vary in layer number, lateral dimension, surface chemistry, defect density 
or quality of the individual graphene sheets, and composition or purity (Fig. 8) 
(Sanchez et al., 2012). Sanchez et al. (2012) proposed a systematic nomenclature 
for the derivatives of graphene and those materials are:  
 
 Figure 7. Structure of graphene. (a) Honeycomb structure of carbon atoms; (b) sp2 hybridized 
orbitals of carbon atoms symmetrically distributed. Adapted from Dash et al. (2014). 
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a) Monolayer graphene can be isolated from graphite by repeated 
“mechanical exfoliation” and is the material that has attracted the most 
interest due to its unique electronic properties;  
b) Few-layer graphene (FLG) is defined as flake-like stacks of 2–10 
graphene layers. It was originally a by-product of, or precursor in, the 
fabrication of monolayer graphene;  
c) Ultrathin Graphite  is defined as material with thickness greater than 10 
sheets (3–5 nm) but less than 100 nm; 
d) Graphene oxide (GO) is a highly oxidized form of chemically modified 
graphene, produced by harsh oxidation of crystalline graphite. The structure 
of GO consists of single-atom-thick carbon sheets with carboxylate groups 
on the periphery;  
e) Reduced graphene oxide (rGO) is the product of treating GO under 
reducing conditions, which include high-temperature thermal treatment and 
chemical treatments with hydrazine (N2H4) or other reducing agents. The 
goal of GO reduction is often done to restore electrical conductivity; 
f) Nano-GO is a term sometimes used to describe graphene oxide of small 
lateral dimension, typically less than 100 nm and often below 20 nm. These 
materials have typically been used in biological applications, because small 
size facilitates cell entry and dispersion stability. 
 
 
 
Figure 8. Structure of Graphene, Graphene Oxide (GO) and Reduced Graphene Oxide (rGO). Adapted from 
Zhang et al. (2016). 
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The properties of GFNs most important for their effects in biological systems 
include surface area, layer number, lateral dimension, surface chemistry, and purity. 
 
 
Surface Area 
 
 
Surfaces play a central role in the biological interactions of nanomaterials 
(Nel et al., 2009). Small nanoparticles (<10 nm) have a significant fraction of their 
atoms exposed on their surfaces. In case of monolayer graphene, every atom lies 
on the surface, and in fact each atom is exposed to the surrounding medium on two 
sides. The surface areas of other GFNs decrease as layer number increases. Due to 
the high surface area of GFNs, physical adsorption or catalytic chemical reaction will 
be important in the biological response to these materials (Sanchez et al., 2012).  
 
 
Layer Number  
 
 
The number of graphene layers in a GFN determines specific surface area 
and bending stiffness (Sanchez et al., 2012). The adsorptive capacity for biological 
molecules increase significantly as layer number decreases. Stiffness is reported to 
be important in the pathological response to fibers and carbon nanotubes (Poland 
et al., 2008).  
The thinnest materials, such as monolayer graphene or GO, are quite 
deformable by weak forces such as water surface tension. The multilayer materials 
in contrast may act as rigid bodies during their cellular interactions.  
 
 
Lateral dimension 
 
 
Lateral dimension determines the maximum dimension of the material, which 
is relevant for cell uptake, renal clearance, blood-brain barrier transport and other 
biological interactions that depend on particle size. Lateral dimension affects the 
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population of receptors needed for uptake, and also the size of the endosome or 
lysosome into which the material must be packaged within the cell. The lateral sizes 
of GFNs span orders of magnitude, from nano-GO at 10 nm (the size of some 
proteins) to >20μm (larger than most cells) (Sanchez et al., 2012).  
 
 
 
 
Surface chemistry 
 
 
The graphene family includes materials with widely varying surface 
chemistry. Graphene oxide surfaces are in part hydrophobic with hydrophilic regions 
capable of hydrogen bonding and metal ion complexing, and contain negative 
charges on edge-sites associated with carboxylate groups. The pristine graphene 
surface, in contrast, is hydrophobic and capable of biochemical reactions primarily 
at edge or defect sites. Reduced graphene oxide is intermediate in hydrophilicity 
and in basal reactivity, since it contains basal vacancy defects produced during 
oxygen removal (Sanchez et al., 2012).  
 
 
Purity  
 
 
Graphene nanomaterials typically do not contain residual metal catalysts. 
However, some of them may contain residual intercalants, chemical additives used 
to separate the layers in the bulk graphite feedstock and have not been fully 
removed by washing. The reagents used in various GFN syntheses include 
permanganate, nitrate, sulphate, chromate, peroxide, persulfate, hydrazine and 
borohydride and associated cations, typically potassium, sodium, or ammonium 
(Sanchez et al., 2012).  
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Graphene applications  
 
Graphene has been used in diverse nanobiotechnological applications, such 
as in the environment, biomedicine and biotechnology.  
Graphene nanomaterials possess potential in the biomedical field as 
biosensors, tissue scaffolds, carriers for drug delivery or gene therapy, antibacterial 
agents, stem cell technology, photo thermal therapy  and bio-imaging (Gulzar et al., 
2017; Ou et al., 2017; Sanchez et al., 2012).  In the last years studies have been 
carried on the delivery of anticancer drugs, genes and peptides via graphene 
derivatives. Recent studies suggest that graphene and GO are able to hasten the 
growth, differentiation, and proliferation of stem cells, and hence possess prodigious 
potential in tissue engineering, regenerative medicine, and other biomedical fields 
(see Gulzar et al., 2017).  
Numerous types of graphene also present other properties such as high 
Raman scattering intensity, large absorption cross section in the NIR (Near infrared 
radiation) region, sharp photoacoustic contrast with the NIR incident beam, which 
all are indispensable properties for bio-imaging (Gulzar et al., 2017).  
Although the application of graphene may provide consistent improvements 
or possible revolutions in the biomedical area, its use is not without risk to human 
health; therefore, a deeper level of nanotoxicological and human safety studies are 
required (Seabra et al., 2014).  
 
 
 
Toxicity of Graphene Nanomaterials  
 
 
GFNs present in biomedical and non-biomedical products manifested 
potential toxicity to humans, animals, and cells (Ou et al., 2017). Due to their size 
graphene nanoparticles can cross the physiological barriers by different exposure 
routes, for example, inhalation, ingestion, dermal penetration, or implantation for 
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biomedical applications. The major exposure route for GFNs in the working 
environment is airway exposure.  
The properties of graphene nanomaterials, such as shape, size, 
concentration, lateral dimension, surface structure, functional groups, purity and 
protein corona influence toxicity in biological systems (Lalwani et al., 2016; Sanchez 
et al., 2012; Seabra et al., 2014; Yang et al., 2013). 
GFNs get into the cell through different ways which lead to several reactions. 
The main mechanisms proposed by Ou et al. (2016) for the cytotoxicity of GFNs 
are: physical destruction, oxidative stress, mitochondrial damage, DNA damage, 
inflammatory response, apoptosis, autophagy and necrosis. A schematic of the main 
mechanisms of GFNs cytotoxicity is illustrated in Figure 9.   
 
 
 
Figure 9. The possible mechanisms of GFNs cytotoxicity. Adapted from Ou et al. (2016).  
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Internalization  
 
Shape, size and curvature of nanomaterials greatly influence the 
internalization of nanomaterials inside a cell. 
Graphene and graphene-related nanomaterials are primarily internalized into 
cells via endocytosis. The internalization of graphene into cells is known to be 
related to the cell type. Macropinocytosis seems to be a general internalization 
process in three different cell lines (Saos-2 osteoblasts, HepG2 hepatoma cells, and 
RAW 264.7 macrophages) (Fig. 10).  The internalization of graphene nanomaterials 
into cells is strongly influenced by the particle size and surface chemistry. Low 
concentrations of graphene nanomaterials show little or no toxicity in mammalian 
cells, however high concentrations of graphene alter the dynamics and integrity of 
the plasma membrane during their internalization, and induce cell death (Zhang et 
al., 2016).  
 
 
Figure 10. The possible internalization pathways of nanoparticles. Adapted from Zhang et al. (2015). 
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ROS Production 
 
Oxidative stress arises when there is a disturbance in the balance between 
the production of reactive oxygen species (ROS) and antioxidant enzymes, including 
catalase, superoxide dismutase (SOD), or glutathione peroxidase (GSH-PX) (Ou et 
al., 2016). Pristine graphene increase intracellular ROS in RAW 264.7 cells which is 
the first step in the mechanisms of carcinogenesis, ageing, and mutagenesis (Li et 
al., 2012). Oxidative stress had a significant role in GO-induced acute lung injury, 
and the inflammatory responses caused by oxidative stress often emerged upon 
exposure to GFNs (Ou et al., 2016). The activity of SOD and GSH-PX decreased 
after exposed to GO in a time- and dosage-dependent manner (Zhang et al., 2010).  
 
 
Mitochondrial damage 
 
Mitochondria are energy production centres, and the mitochondrial 
membrane potential (MMP) is crucial to ATP synthesis. Pristine graphene induced 
cytotoxicity in RAW 264.7 cells through the depletion of the MMP (Li et al., 2012).  
GO caused the disturbance of the mitochondrial structure and function, as 
characterized by a decrease in the mitochondrial membrane potential and the 
dysregulation of mitochondrial Ca2+ homeostasis (Lammel et al., 2013). Direct 
influence of GFNs in cell mitochondrial activity can cause apoptosis and/or cell 
necrosis (Park et al., 2015; Shekaramiz, 2012). 
 
 
DNA damage 
 
Due to its small size, high surface area and surface charge, GFNs may 
possess significant genotoxic properties and cause severe DNA damage.  
Carbon nanotubes (CNT) - allotropes of carbon with a cylindrical nanostructure -  
are capable of increasing chromosome and DNA damage as assessed by the 
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cytokinesis-blocked micronucleus and comet assays, respectively, in RAW 264.7 
murine macrophages (Migliore et al., 2010). 
GO can elevate the expression of p53, Rad51, and MOGG1-1, which reflect 
chromosomal damage, and decrease the expression of CDK2 and CDK4 by arresting 
the cell cycle transition from the G1 to the S phase in various cell lines. (Liu et al., 
2013). GO may induce chromosomal fragmentation, DNA adducts and point 
mutations by promoting oxidative stress or triggering inflammation through the 
activation of intracellular signalling pathways such as MAPK, TGF-β and NF-κB 
(Chatterjee et al., 2014; Liu et al., 2013; Jarosz et al., 2015). GO caused DNA 
damages in HEK293T cells and induced base excision repair pathway in both 
HEK293T cells and zebrafish embryos (Lu et al., 2017).  
Graphene-family nanomaterials (GFNs) possibly caused DNA damage to 
human bronchial epithelial cells by affecting nucleotide excision repair and non-
homologous end joining repair systems (Chatterjee et al., 2016).  
 
 
Apoptosis 
 
Apoptosis is a genetically regulated process leading to the death of cells. It is 
a coordinated process that can be triggered through two different pathways, the 
death-receptor pathway (triggered by members of the death-receptor superfamily) 
and the mitochondrial pathway (in response to internal DNA damage) (Li et al., 
2012). Wang et al. (2011) demonstrated that graphene oxide could produce 
cytotoxicity and can enter human lung fibroblasts cytoplasm and nucleus, inducing 
apoptosis at doses above 20 µg/ml after 24 h. rGO induced cell death in glioma cells  
mostly through the apoptosis pathway (Jaworski et al., 2015).  Exposure of Raw 
264.7 cells to pristine graphene caused an increase of apoptosis by activation of the 
mitochondrial pathway (Li et al., 2012). GFNs also had pro-apoptotic effects in cells 
(Ou et al., 2016).  
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Graphene can increase EGFR (epidermal growth factor receptor) expression 
in lung epithelial cells, which mediate several cell pathways that include enhancing 
the apoptosis progress (Fig. 11) (Tsai et al., 2017).  
 
 
 
 
 
Necrosis 
 
Necrosis can be defined as cell death caused by loss of membrane integrity, 
intracellular organelle swelling and adenosine triphosphate (ATP) depletion leading 
to an influx of calcium (Cullen, 2010).  
The exposure of cells to pristine graphene caused necrosis at high doses (50 
mg/mL) (Li et al., 2012). GO treatment was revealed to induce necrosis in 
macrophages by activating TLR4 signalling and subsequently partly triggering 
autocrine TNF-α production (Qu et al., 2013).  
 
 
 
Figure 11.  The model of how graphene induces EGFR activation. Adapted from Tsai et al. (2017).  
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In summary, many studies have discussed representative mechanisms of 
GFNs toxicity involving four signalling pathways: TLRs, TGF-β, TNF-α and MAPKs. 
These four signalling pathways are correlative and cross-modulatory, making the 
mitochondrial damage, apoptosis and other mechanisms independent and yet 
connected to each other. Additionally, oxidative stress appears to play the most 
important role in activating these signalling pathways (Ou et al., 2016). 
 
 
II. Assay Techniques  
 
 
In vitro cell culture  
 
 The removal of cells from an animal or plant and their subsequent growth in 
a favourable environment is called cell culture. A primary cell culture may be 
obtained by disaggregating the tissue mechanically or enzymatically to produce a 
suspension of cells, some of which will ultimately attach to the substrate (Fig. 12). 
Primary culture refers to the stage of the culture after the cells are isolated from 
the tissue or organ and attached, divided and proliferated under the appropriate 
conditions until they reach confluence. Then, they must be subcultured to give them 
room for continued growth by transferring them to a new vessel with fresh growth 
medium. This constitutes a “passage” and the daughter cultures so formed are the 
beginnings of a cell line (Freshney, 1993; Helgason & Miller, 2004).  
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Figure 12. Primary cell culture. Adapted from Wagner & Hewlett (2004).  
 
 
Two basic systems are used for growing cells in culture, as monolayers on 
an artificial substrate (i.e., adherent culture) or free-floating in the culture medium 
(suspension culture). Cells in culture can be divided into three categories based on 
their morphology (Fig. 13):  
 
 Epithelial-like: cells that are attached to a substrate and appear flattened and 
polygonal in shape;  
 
 Lymphoblast-like: cells that do not attach normally to a substrate but 
remain in suspension with a spherical shape; 
 
 Fibroblast-like: cells that are attached to a substrate and appear elongated 
and bipolar, frequently forming swirls in heavy cultures.   
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The characteristics of in vitro cultured cells are determined by both their 
origin (liver, heart, etc.) and how they adapt to the culture conditions. Biochemical 
markers can be used to determine if cells are still carrying the specialized functions 
they presented in vivo. Frequently, these characteristics are either lost or changed 
due to the artificial environment. Some cell lines will eventually stop dividing and 
show signs of aging. Other lines are, or become immortal; these can continue to 
divide indefinitely.  Continuous culture of cell lines can lead to the accumulation of 
unwanted karyotype alterations or the outgrowth of clones within the population. 
In addition, continuous growth increases the possibility of cell line contamination by 
bacteria or other unwanted organisms.  
In vitro cell culture is an invaluable tool for investigators in numerous fields. 
It facilitates analysis of biological properties and processes that are not readily 
accessible at the level of the intact organism. This is one of the main tools used in 
cellular and molecular biology, allowing the study of the normal physiology and 
biochemistry of cells, the effects of chemicals on the cells and its potential 
mutagenic and carcinogenic effects. It is also used in drug screening and 
development, and large scale manufacturing of biological compounds, such as 
vaccines, therapeutic and proteins. The major advantage of using cell culture is the 
consistency and reproducibility of results that can be obtained from using clonal 
cells.  
The major requirement of a cell culture laboratory is the need to maintain an 
aseptic work area that is restricted to cell culture work. Aseptic technique, designed 
Figure 13. A - Epithelial-like cells; B - Lymphoblast-like cells; C - Fibroblast cells. 
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to provide a barrier between the microorganisms in the environment and the sterile 
cell culture, depends upon a set of procedures to reduce the probability of 
contamination from these sources. The elements of aseptic technique are a sterile 
work area, good personal hygiene, sterile reagents and media, and sterile handling 
(Freshney, 1993; Helgason & Miller, 2004). 
 
 
Assays for genotoxicity evaluation 
 
 
Cytokinesis-blocked micronucleus cytome assay 
 
The DNA is an intrinsically reactive molecule and is highly susceptible to chemical 
modifications by endogenous and exogenous agents that can impact health and 
modulate disease-states, therefore the study of DNA damage is an essential part of 
genetic toxicology. 
The cytokinesis-blocked micronucleus assay (CBMN) is one of the most 
commonly used methods for measuring DNA damage and cytotoxicity. DNA damage 
is scored specifically in once-divided binucleated (BN) cells and include micronuclei 
(MNi), nucleoplasmic bridges (NPBs), and nuclear buds (NBUDs) (Fig. 14). MNi are 
small extranuclear bodies resulting from chromosome fragments or whole 
chromosomes lagging behind during anaphase. NPBs originate from dicentric 
chromosomes that may be caused by misrepair of double strand DNA breaks or 
telomere end fusions (Fenech, 2007). Cells that have completed one nuclear division 
are blocked by cytochalasin-B (Cyt-B), an actin polymerization inhibitor, and are 
consequently identified by their binucleated appearance (Fenech, 2000).  
This method is an efficient assay of DNA damage, chromosomal instability, 
mitotic abnormalities, cytostasis and cell death. CBMN assay allows the measure of 
many events of cellular and nuclear dysfunction such as unrepaired chromosome 
breaks, DNA misrepair, telomere end fusions, chromosomal instability, altered 
mitotic activity and/or cytostasis and cell death by necrosis or apoptosis.  
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Figure 14. MN and NPB formation in cells during nuclear division. These events can only be observed in BN 
cells after cytokinesis blocking with Cyt-B. Adapted from Fenech (2007). 
 
Figure 15 shows a representative example of the possible biomarkers present 
in cells scored in the CBMN assay. The CBMN assay is the preferred method for 
measuring MNi in cultured human and mammalian cells because scoring is 
specifically restricted to once-divided BN cells, which are the cells that can express 
MNi.  
 
 
 
Figure 15. Photomicrographs of the cells scored in the CBMN assay. (a) Mononucleated cell; 
(b) BN cell; (c) multinucleated cell; (d) early necrotic cell; (e) late apoptotic cell; (f) BN cell 
containing one MNi; (g) BN containing an NPB (and a MN); (h) BN cell containing NBUDs. Adapted from Fenech 
(2007). 
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The Comet Assay  
 
The comet assay or single cell gel electrophoresis (SCGE) assay is a gel 
electrophoresis–based method that can be used to measure DNA damage in 
individual eukaryotic cells (Olive & Banáth, 2006), with applications in genotoxicity 
testing, human biomonitoring and molecular epidemiology, as well as fundamental 
research in DNA damage and repair (Collins, 2004).  
This assay is a rapid, sensitive and relatively simple method and combines 
biochemical techniques for detecting DNA single strand breaks with the single cell 
approach typical of cytogenetic assays.  
The Comet Assay is based on the ability of negatively charged 
loops/fragments of DNA to be drawn through an agarose gel in response to an 
electric field. The extent of DNA migration depends directly on the DNA damage 
present in the cells (Fig. 16). It should be noted that DNA lesions consisting of 
strand breaks after treatment with alkali either alone or in combination with certain 
enzymes (e.g. endonucleases) increases DNA migration, whereas DNA-DNA and 
DNA-protein cross-links result in retarded DNA migration compared to those in 
concurrent controls (Tice et al., 2000). The comet assay is most commonly applied 
to animal cells, whether in culture or isolated from the organism (Collins, 2004). 
 
 
Figure 16. Images of comets (from lymphocytes), stained with DAPI. They represent 5 classes from 0 (no tail) 
to 4 (almost all DNA in tail) (Collins, 2004).  
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III. Raw 264.7 cell line  
 
 
 
Potential target cells in the lungs following inhalation of GFNs include alveolar 
macrophages, lung epithelial cells, and fibroblasts in the interstitium of the alveolar 
walls (Sanchez et al., 2012). Macrophages play a key role in the cellular response 
and represent the active line of defence against inhaled particles that deposit in the 
lungs. Studies have been conducted to evaluate their property of initiating and 
propagating inflammatory reactions (Kagan et al., 2006; Oberdörster et al., 2005). 
The macrophage cell line RAW 264.7used in the present study was isolated 
from Mus musculus, which are derived from Abelson murine leukaemia virus-
induced tumour. This lineage is considered a representative model for the study of 
lung responses to inhaled NPs and ultrafine particles (Fig. 17). This cell line is easy 
to propagate, highly efficient for DNA transfection, sensitivity to RNA interference, 
and supports replication of murine noroviruses (ATCC, 2016).  
The base medium for this cell line is ATCC-formulated Dulbecco's Modified 
Eagle's Medium (DMEM) and to make the complete growth medium, it is necessary 
to supplement it with fetal bovine serum (FBS). The requirements for cell growth 
are atmosphere of 95% oxygen and 5% carbon dioxide at a temperature of 37ºC 
to ensure the conditions necessary for growth. 
 
 
 
Figure 17. RAW 264.7 cells in culture.  
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IV. Aims  
 
 
 
The general aim was to perform a comprehensive study on the genotoxicity of 
seven graphene nanomaterials to macrophage RAW 264.7 cells using carbon black 
as reference, to establish a toxicity ranking.  
 
 
 
 
 
V. Materials and Methods  
 
 
 
Test Materials and Characterization 
 
For the current study, 7 GFNs compounds were selected (P1-P7) and carbon 
black (P8) was used as reference (Table 2):  
 
P1. Single-Layer Graphene Powder; 
P2. Single-Layer Graphene from factory series; 
P3. Carboxyl Graphene;  
P4. Graphene Nanoplatelets; 
P5. Graphene Oxide Powder (S Method); 
P6. Graphite Oxide Powder; 
P7. Reference Pristine Graphene Nanoplatelets; 
P8. Reference Carbon Black particles.  
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Table 2. Detailed information of the several nanomaterials used in this study. 
 
Sample 
Source 
Product 
Diameter 
(µm) 
Thickness 
Specific 
surface 
(m2/g) 
SEM 
image 
Preparations/ 
Properties 
P1 
 
ACS 
GN1P 
0005 
 
 
~5 
 
 
2-10  
 
 
278  
(400-
1000) 
 
 
Thermal exfoliation 
reduction + 
Hydrogen reduction 
P2 
 
ACS 
GN1PF 
 
 
0.5-5  
 
 
2-10  
 
 
620  
(650-750) 
 
 
1-5 atomic layer 
graphene 
nanosheets 
P3 
 
ACS 
GN1PF 
010 
 
 
 
1-5  
 
 
 
0.8-1.2  
 
 
 
1.5 
 1 – Modified 
Hummer’s method 
to make graphene 
oxide; 
2 – Convert –OH 
and C-O-C 
into –COOH. 
Carboxyl ratio: 5% 
P4 
 
ACS 
GNNP 
0051 
 
 
~5  
 
 
2-10  
 
 
15 (20-40) 
 
 
Stacks of multi-
layer graphene, 
with a high aspect 
ratio, 
width to thickness 
P5 
 
ACS 
GNOS 
0010 
 
 
 
1-15  
 
 
 
0.8-1.2  
 
 
 
5.2 (5-10) 
 
 
 
Stauden-maier 
method; 
oxygen content: 
35% 
P6 
 
ACS 
GTOP 
0002 
 
 
0.5-5  
 
 
1-3  
 
 
2.7 
 
 
Modified Hummer’s 
method: 
oxygen content: 
35% 
P7  
 
 
AVANZARE  
 
 
2  
 
 
3  
 
 
195 (70) 
 
No XPS (low 
defects by RAMAN) 
all 
CS1 carbons. 8±0.5 
atomic 
layer graphene 
P8 
 
Evonik 
Degussa 
 
 
14  
 
 
- 
 
  
 
 
317 (337) 
 
 
 
Specified as >99% 
pure 
carbon black 
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Cell Line Culture  
 
For this study, the RAW 264.7 cell line was used as a model. Cells were 
cultured in 75 cm2 culture flasks with 10mL Dulbecco’s modified Eagle’s medium 
(DMEM), supplemented with 10% (v/v) Fetal Bovine Serum (FBS), 1% L-glutamine, 
1% penicillin/streptomycin, and 1% fungizone. The cell cultures were maintained in 
a humidified atmosphere (5% CO2) at 37°C. The cells were observed every day 
under the inverted microscope (Nikon®Eclipse TS100) to check if there were 
contaminations and to evaluate their morphology and confluence (% of cell 
coverage on the surface area of the flask). The cells were subcultured every 2-3 
days, when cultures reached about 70-80% confluence. The medium was removed 
and the cells were washed with phosphate buffered saline-PBS. To harvest cells 
from culture flasks a cell scraper was used, and the cell suspension was resuspended 
in culture medium and counted using a Neubauer chamber. The last step of the 
process was the seeding of cells in new flask with complete culture medium at the 
conditions already described. Aseptic techniques suitable for cell culture were 
followed throughout the experiments. 
 
 
Exposure to GFNs 
 
Cells were seeded in 12 and 6 well plates and incubated for 24h at 37°C, 5% 
CO2, to adhere. After that period, the culture medium was removed and replaced 
for the same amount of the appropriate dilutions of GFNs. The concentrations for 
exposure were defined based in previous studies in which RAW 264.7 cells were 
exposed to a range of 0.00-50.00 µg/cm2 GFNs for 24h and 48h and cell viability 
was assessed by AlamarBlue (AB) and lactate dehydrogenase (LDH) assays 
(Menezes et al, 2017).  
The benchmark dose 30 (BMD30) and 0.5 BMD30 of each GFN for 24h were 
selected for the cell exposure in the subsequent assays and are shown in detail in 
table 3 (Menezes et al., 2017).  
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Table 3. Concentrations of particles per area.  
Sample Concentration for 
BMD30 (µg/cm2) 
Concentration for 
0.5BMD30 (µg/cm2) 
P1 46.8 23.4 
P2 50 25 
P3 22 11 
P4 25.3 12.7 
P5 29.4 14.7 
P6 23.6 11.8 
P7 50 25 
P8 50 25 
 
 
 
Cytokinesis-blocked micronucleus cytome assay 
 
To assess the genotoxic effects of GFNs in RAW 264.7 macrophages, the 
CBMN assay was performed as follows. Before seeding the cells, a coverslip was 
placed in each well of a twelve-well plate. The appropriate dilutions were made and 
a suitable quantity of cells (2 x 104 cells/cm2) was seeded into each well, and two 
paired, independent cultures for each concentration were prepared. After 24 hours, 
the macrophages were treated with each GFN as described earlier. Cells exposed to 
methanesulfonate (MMS) at 25µg/mL were used as a positive control.  
Forty-four hours after the initial preparation of the cultures, cytochalasin B 
was added to each test well to a final concentration of 4 µg/ ml to block cytokinesis 
(Fenech, 2007) followed by an incubation period of 28 hours. Then the medium was 
removed and each well was washed with 1mL of PBS.  Absolute methanol cooled at 
4°C (2mL) was added to each well to fix the cells (10min). The slides were stained 
with 1% acridine orange for 30 seconds, and mounted with one drop of cold distilled 
water. The slides were observed under the fluorescence microscope with an 
excitation filter of 450-490 nm and a barrier filter of 520 nm.  
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VI. Results and discussion  
 
 
 
 
Graphene family nanomaterials have drawn much scientific attention and 
technological interest since their discovery due to their unique electronic and 
mechanical properties (Jastrzębska et al., 2012). 
Previous studies with different cellular or animal model have demonstrated 
that some of the graphene derivatives induced significant cytotoxicity and 
genotoxicity. The interactions of graphene with cells, proteins, and other 
biomolecules are influenced by its physiochemical properties such as shape, size, 
surface charge, stability and purity and contribute to the differential toxicity 
observed (Park et al., 2015; Wang et al., 2013). Also for graphene-based materials 
it was reported that the different physicochemical properties result in different 
cellular toxicities (Ou et al., 2017; Zhang et al., 2014). In vitro toxicity investigation 
suggests that graphene exhibit dose-dependent toxicity to mammalian cells 
(Jastrzębska et al., 2012).  
Figure 18 shows the effect of exposure for 24h of graphene nanoplatelets at 
0.5 BMD30dose to RAW264.7 cells. Microscopic observations of cell cultures showed 
decreased cell confluence and increased the number of dead cells. 
 
 
 
 
Figure 18. Microscopic images of RAW264.7. A – RAW264.7 cells in control conditions, B - Microscopic 
images of RAW264.7. B -RAW264.7 cells to 0.5BMD30 of P4 after 24 hours of exposition. 
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The main mechanism of graphene toxicity is associated with the generation 
of intracellular reactive oxygen species that cause damage to proteins and DNA 
leading to cell death via apoptotic or necrotic pathways (Li et al., 2012; Ma et al., 
2014; Zhang et al., 2012). Some studies have shown that GFNs could cause 
epigenetic and genomic changes that might stimulate physical toxicity and 
carcinogenicity (Soldano et al., 2010; Max Costa & Yao, 2013).  
In the present thesis, preliminary studies on the effects of several GFNs on 
the micronuclei (MNi) induction (assessed by the cytokinesis-block micronucleus 
cytome assays, CBMN) were performed. Cells exposed to methanesulfonate (MMS) 
at 25 µg/mL were used as a positive control. In the first analysis of the slides it was 
verified that there were many multinucleated cells instead of the expected 
binucleated cells, which made it difficult to visualise the cells. This may have 
happened due to the concentration of cytochalasin B added to each test well.  The 
time of exposure may not have been adequate either. An adjustment to time and 
concentration of cytochalasin B should be made in future studies with the Raw 264.7 
cell line. Evaluation and interpretation of results were not performed.  
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VII. Conclusions - Future Perspectives  
 
 
 
Presently, the literature is insufficient to draw conclusions about the potential 
hazards of GFNs. Considering that humans are usually exposed to GFNs, especially 
at their manufacture, it is important to determine if or which GFNs are more 
cytotoxic.   
For all future studies of GFNs toxicity it is very important a detailed 
physiochemical characterization since these physicochemical factors influence the 
toxicity and biocompatibility of GFNs. The selection of cell lines is of vital importance 
because some of them tend to be sensitive or resistant depending upon their genetic 
background. The same graphene nanoparticles can cause different reactions 
depending on their various cells origins. More specific signalling pathways in the 
mechanism of GFNs toxicity need to be discovered and elucidated. A deeper study 
on the mechanisms underlying cytotoxicity by GFNs could be performed, for 
instance, the analysis of cytochrome c to better understand the relation between 
mitochondrial physiology and the release of cytochrome in apoptosis initiation. ATP 
measurements, protein expression and autophagy studies are also recommended. 
For all types of graphene nanoparticles, it is important to investigate and 
critically evaluate the potential short- and long-term health risks and toxicity hazards 
after acute, sub-acute and chronic exposures using in vitro and in vivo models.  
Finally, there is a need for systemic solutions, monitoring and recording of 
potential hazard of GFNs as well as finding timely responses in order to achieve 
safety for human health and environment.  
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